Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

94
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
94
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

17.0K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
17.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safe and Early Primary Closure of Open Abdomen in Pediatric Liver Transplantation Using a Doppler-Guided Tension Relief Strategy and Enhanced Wound Environment.

Journal of transplantation·2026
Same author

Human biliary atresia extrahepatic cholangiocyte organoids express increased ER and oxidative stress, altered drug metabolism and cell polarity changes.

Frontiers in bioengineering and biotechnology·2026
Same author

A plain language summary on clinical and mechanistic effects of cladribine in relapsing multiple sclerosis: 2-year results from the MAGNIFY-MS study.

Neurodegenerative disease management·2026
Same author

Excellent Outcome of Residual Pulmonary Metastases in Initially High Burden Metastatic Hepatoblastoma: A Case Series.

Journal of pediatric hematology/oncology·2026
Same author

Laparoscopic Living Donor Nephrectomy: Learning Curve Analysis Through 1446 Cases and Outcomes from 200 Consecutive Mastery-Phase Procedures-How I Do It.

Journal of clinical medicine·2026
Same author

Neurofilament Light Chain Measurements by Centaur and Simoa Systems in Human and Murine Samples.

The Israel Medical Association journal : IMAJ·2026

Related Experiment Video

Updated: Apr 15, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.9K

Optimizing multiple sclerosis diagnosis: gene expression and genomic association.

Michael Gurevich1, Gadi Miron1, Anat Achiron2

  • 1Multiple Sclerosis Center, Sheba Medical Center Ramat-Gan, Israel.

Annals of Clinical and Translational Neurology
|March 28, 2015
PubMed
Summary
This summary is machine-generated.

A new blood gene expression test aids in diagnosing multiple sclerosis (MS) at its first demyelinating event. This tool helps differentiate MS from other neurological conditions, improving early diagnosis.

More Related Videos

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.7K
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

8.5K

Related Experiment Videos

Last Updated: Apr 15, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.9K
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.7K
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

8.5K

Area of Science:

  • Neurology
  • Genetics
  • Immunology

Background:

  • Diagnosing multiple sclerosis (MS) at onset is challenging due to similar symptoms and radiological findings in other neurological conditions (NonMS).
  • Genome-Wide Association Studies (GWAS) have identified numerous MS susceptibility genes, providing a basis for molecular diagnostics.

Purpose of the Study:

  • To develop a blood gene expression-based classification tool for diagnosing MS during the initial demyelinating event.
  • To improve diagnostic accuracy and aid in differentiating MS from NonMS conditions.

Main Methods:

  • Integrated data from 110 MS susceptibility genes (from GWAS) and differential blood gene expression profiling (80 MS vs. 31 NonMS patients).
  • Applied various classification algorithms to create a diagnostic classifier.
  • Validated the classifier's accuracy on an independent cohort of 146 patients (121 MS, 25 NonMS).

Main Results:

  • Developed a 42-gene transcript expression classifier for MS diagnosis.
  • Achieved a 76.0 ± 3.5% accuracy rate in an independent, diagnostically challenging patient cohort.
  • Demonstrated effectiveness even with NonMS patients exhibiting positive MRI findings.

Conclusions:

  • The gene expression classifier serves as a valuable adjunct to the McDonald criteria for MS diagnosis.
  • This tool assists in accurately excluding other neurological diseases presenting with the first demyelinating event suggestive of MS.